{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T02:56:45Z","timestamp":1773370605896,"version":"3.50.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T00:00:00Z","timestamp":1769472000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T00:00:00Z","timestamp":1769472000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"W.H. Odell Professorship in Individualized Medicine (Boughey)."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1245\/s10434-025-18776-7","type":"journal-article","created":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T18:32:23Z","timestamp":1769538743000},"page":"3273-3282","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cost-Effectiveness Analysis of Axillary Management Options at the Time of Contralateral Prophylactic Mastectomy"],"prefix":"10.1245","volume":"33","author":[{"given":"Christopher D.","family":"Vetter","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judy C.","family":"Boughey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey E.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,27]]},"reference":[{"issue":"4","key":"18776_CR1","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.jamcollsurg.2008.06.139","volume":"207","author":"A Karam","year":"2008","unstructured":"Karam A, Stempel M, Cody HS 3rd, Port ER. Reoperative sentinel lymph node biopsy after previous mastectomy. J Am Coll Surg. 2008;207(4):543\u20138. https:\/\/doi.org\/10.1016\/j.jamcollsurg.2008.06.139.","journal-title":"J Am Coll Surg."},{"issue":"2","key":"18776_CR2","doi-asserted-by":"publisher","first-page":"237","DOI":"10.4103\/ijc.IJC_1175_20","volume":"60","author":"H Kara","year":"2023","unstructured":"Kara H, Arikan AE, D\u00fclgero\u011flu O, Uras C. Sentinel lymph node biopsy after nipple-sparing mastectomy in early postoperative period: Is it feasible? Indian J Cancer. 2023;60(2):237\u201341. https:\/\/doi.org\/10.4103\/ijc.IJC_1175_20.","journal-title":"Indian J Cancer."},{"issue":"5","key":"18776_CR3","doi-asserted-by":"publisher","DOI":"10.1097\/GOX.0000000000004344","volume":"10","author":"MS Shaheen","year":"2022","unstructured":"Shaheen MS, Momeni A. Nationwide trends in contralateral prophylactic mastectomies: An analysis of 55,060 unilateral breast cancer patients. Plast Reconstr Surg Glob Open. 2022;10(5):e4344. https:\/\/doi.org\/10.1097\/GOX.0000000000004344.","journal-title":"Plast Reconstr Surg Glob Open"},{"issue":"3","key":"18776_CR4","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1097\/SLA.0000000000001698","volume":"265","author":"SM Wong","year":"2017","unstructured":"Wong SM, Freedman RA, Sagara Y, Aydogan F, Barry WT, Golshan M. Growing use of contralateral prophylactic mastectomy despite no improvement in long-term survival for invasive breast cancer. Ann Surg. 2017;265(3):581\u20139. https:\/\/doi.org\/10.1097\/SLA.0000000000001698.","journal-title":"Ann Surg"},{"key":"18776_CR5","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1002\/jso.27088","volume":"127","author":"JL Thompson","year":"2023","unstructured":"Thompson JL, Sinco BR, McCaffrey RL, et al. Prophylactic mastectomy and occult malignancy: surgical and imaging considerations. J Surg Oncol. 2023;127:18\u201327. https:\/\/doi.org\/10.1002\/jso.27088.","journal-title":"J Surg Oncol."},{"issue":"5","key":"18776_CR6","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1002\/cncr.20517","volume":"101","author":"TA King","year":"2004","unstructured":"King TA, Ganaraj A, Fey JV, et al. Cytokeratin-positive cells in sentinel lymph nodes in breast cancer are not random events: experience in patients undergoing prophylactic mastectomy. Cancer. 2004;101(5):926\u201333. https:\/\/doi.org\/10.1002\/cncr.20517.","journal-title":"Cancer."},{"issue":"7","key":"18776_CR7","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1002\/cncr.22176","volume":"107","author":"JC Boughey","year":"2006","unstructured":"Boughey JC, Khakpour N, Meric-Bernstam F, et al. Selective use of sentinel lymph node surgery during prophylactic mastectomy. Cancer. 2006;107(7):1440\u20137. https:\/\/doi.org\/10.1002\/cncr.22176.","journal-title":"Cancer."},{"issue":"9","key":"18776_CR8","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.1245\/s10434-007-9356-1","volume":"14","author":"D Black","year":"2007","unstructured":"Black D, Specht M, Lee JM, et al. Detecting occult malignancy in prophylactic mastectomy: preoperative MRI versus sentinel lymph node biopsy. Ann Surg Oncol. 2007;14(9):2477\u201384. https:\/\/doi.org\/10.1245\/s10434-007-9356-1.","journal-title":"Ann Surg Oncol."},{"issue":"6","key":"18776_CR9","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1002\/cncr.23298","volume":"112","author":"SA McLaughlin","year":"2008","unstructured":"McLaughlin SA, Stempel M, Morris EA, Liberman L, King TA. Can magnetic resonance imaging be used to select patients for sentinel lymph node biopsy in prophylactic mastectomy. Cancer. 2008;112(6):1214\u201321. https:\/\/doi.org\/10.1002\/cncr.23298.","journal-title":"Cancer."},{"issue":"6","key":"18776_CR10","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1016\/j.jamcollsurg.2009.08.010","volume":"209","author":"C Laronga","year":"2009","unstructured":"Laronga C, Lee MC, McGuire KP, et al. Indications for sentinel lymph node biopsy in the setting of prophylactic mastectomy. J Am Coll Surg. 2009;209(6):746\u201352. https:\/\/doi.org\/10.1016\/j.jamcollsurg.2009.08.010.","journal-title":"J Am Coll Surg."},{"issue":"7","key":"18776_CR11","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1002\/jso.23018","volume":"105","author":"IA Czyszczon","year":"2012","unstructured":"Czyszczon IA, Roland L, Sahoo S. Routine prophylactic sentinel lymph node biopsy is not indicated in women undergoing prophylactic mastectomy. J Surg Oncol. 2012;105(7):650\u20134. https:\/\/doi.org\/10.1002\/jso.23018.","journal-title":"J Surg Oncol."},{"issue":"8","key":"18776_CR12","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1002\/jso.23575","volume":"109","author":"PW Bunting","year":"2014","unstructured":"Bunting PW, Cyr AE, Gao F, Margenthaler JA. Sentinel lymph node biopsy during prophylactic mastectomy: is there a role? J Surg Oncol. 2014;109(8):747\u201350. https:\/\/doi.org\/10.1002\/jso.23575.","journal-title":"J Surg Oncol."},{"issue":"10","key":"18776_CR13","doi-asserted-by":"publisher","first-page":"3032","DOI":"10.1245\/s10434-017-5925-0","volume":"24","author":"BL Murphy","year":"2017","unstructured":"Murphy BL, Glasgow AE, Keeney GL, Habermann EB, Boughey JC. Selective use of sentinel lymph node surgery in patients undergoing prophylactic mastectomy using intraoperative pathology. Ann Surg Oncol. 2017;24(10):3032\u20137. https:\/\/doi.org\/10.1245\/s10434-017-5925-0.","journal-title":"Ann Surg Oncol."},{"issue":"3","key":"18776_CR14","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1245\/s10434-015-4896-2","volume":"23","author":"D Mattos","year":"2016","unstructured":"Mattos D, Gfrerer L, Ling IT, et al. Occult histopathology and its predictors in contralateral and bilateral prophylactic mastectomies. Ann Surg Oncol. 2016;23(3):767\u201375. https:\/\/doi.org\/10.1245\/s10434-015-4896-2.","journal-title":"Ann Surg Oncol."},{"issue":"11","key":"18776_CR15","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1001\/jamaoncol.2023.3759","volume":"9","author":"OD Gentilini","year":"2023","unstructured":"Gentilini OD, Botteri E, Sangalli C, et al. Sentinel lymph node biopsy vs no axillary surgery in patients with small breast cancer and negative results on ultrasonography of axillary lymph nodes: the SOUND randomized clinical trial. JAMA Oncol. 2023;9(11):1557\u201364. https:\/\/doi.org\/10.1001\/jamaoncol.2023.3759.","journal-title":"JAMA Oncol."},{"issue":"11","key":"18776_CR16","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1056\/NEJMoa2412063","volume":"392","author":"T Reimer","year":"2025","unstructured":"Reimer T, Stachs A, Veselinovic K, et al. Axillary surgery in breast cancer - primary results of the INSEMA trial. N Engl J Med. 2025;392(11):1051\u201364. https:\/\/doi.org\/10.1056\/NEJMoa2412063.","journal-title":"N Engl J Med."},{"issue":"6","key":"18776_CR17","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1002\/bjs.11110","volume":"106","author":"A Karakatsanis","year":"2019","unstructured":"Karakatsanis A, Hersi AF, Pistiolis L, et al. Effect of preoperative injection of superparamagnetic iron oxide particles on rates of sentinel lymph node dissection in women undergoing surgery for ductal carcinoma in situ (SentiNot study). Br J Surg. 2019;106(6):720\u20138. https:\/\/doi.org\/10.1002\/bjs.11110.","journal-title":"Br J Surg."},{"issue":"2","key":"18776_CR18","doi-asserted-by":"publisher","first-page":"241","DOI":"10.2214\/AJR.21.26561","volume":"218","author":"AS Taliaferro","year":"2022","unstructured":"Taliaferro AS, Price ER, Hayward JH, et al. Utility and outcomes of preoperative screening breast MRI for planned bilateral prophylactic mastectomy in high-risk patients. AJR Am J Roentgenol. 2022;218(2):241\u20138. https:\/\/doi.org\/10.2214\/AJR.21.26561.","journal-title":"AJR Am J Roentgenol."},{"issue":"3","key":"18776_CR19","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.amjsurg.2017.03.006","volume":"214","author":"MK Tasoulis","year":"2017","unstructured":"Tasoulis MK, Hughes T, Babiera G, Chagpar AB. Sentinel lymph node biopsy in low risk settings. Am J Surg. 2017;214(3):489\u201394. https:\/\/doi.org\/10.1016\/j.amjsurg.2017.03.006.","journal-title":"Am J Surg."},{"issue":"5","key":"18776_CR20","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1007\/s00330-017-5127-y","volume":"28","author":"C Spick","year":"2018","unstructured":"Spick C, Bickel H, Polanec SH, Baltzer PA. Breast lesions classified as probably benign (BI-RADS 3) on magnetic resonance imaging: a systematic review and meta-analysis. Eur Radiol. 2018;28(5):1919\u201328. https:\/\/doi.org\/10.1007\/s00330-017-5127-y.","journal-title":"Eur Radiol."},{"key":"18776_CR21","doi-asserted-by":"crossref","unstructured":"Sturz-Ellis JL, Vetter CD, Day CN, Boughey JC. A Systematic Review of Occult Malignancy and Sentinel Lymph Node Metastasis at the Time of Contralateral Prophylactic Mastectomy Ann Surg Oncol. 2025. [In Press]","DOI":"10.1245\/s10434-025-18474-4"},{"issue":"1","key":"18776_CR22","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1245\/s10434-015-4660-7","volume":"23","author":"LM Erdahl","year":"2016","unstructured":"Erdahl LM, Boughey JC, Hoskin TL, Degnim AC, Hieken TJ. Contralateral prophylactic mastectomy: factors predictive of occult malignancy or high-risk lesion and the impact of MRI and genetic testing. Ann Surg Oncol. 2016;23(1):72\u20137. https:\/\/doi.org\/10.1245\/s10434-015-4660-7.","journal-title":"Ann Surg Oncol."},{"key":"18776_CR23","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.o1226","volume":"377","author":"J Wise","year":"2022","unstructured":"Wise J. Breast cancer: NICE recommends innovative magnetic technology for locating sentinel lymph nodes. BMJ. 2022;377:o1226. https:\/\/doi.org\/10.1136\/bmj.o1226.","journal-title":"BMJ"},{"issue":"1","key":"18776_CR24","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.surg.2016.03.014","volume":"160","author":"F Gani","year":"2016","unstructured":"Gani F, Ejaz A, Makary MA, Pawlik TM. Hospital markup and operation outcomes in the United States. Surgery. 2016;160(1):169\u201377. https:\/\/doi.org\/10.1016\/j.surg.2016.03.014.","journal-title":"Surgery."},{"key":"18776_CR25","doi-asserted-by":"publisher","first-page":"e18917","DOI":"10.1200\/JCO.2023.41.16_suppl.e18917","volume":"41","author":"Kimberly Badal","year":"2023","unstructured":"Badal Kimberly, et al. Cost of breast cancer screening in the USA: comparison of current practice, advocated guidelines, and a personalized risk-based approach. JCO. 2023;41:e18917\u2013e18917. https:\/\/doi.org\/10.1200\/JCO.2023.41.16_suppl.e18917.","journal-title":"JCO"},{"issue":"2","key":"18776_CR26","doi-asserted-by":"publisher","first-page":"253","DOI":"10.3390\/cancers11020253","volume":"11","author":"MM Jonczyk","year":"2019","unstructured":"Jonczyk MM, Jean J, Graham R, Chatterjee A. Trending towards safer breast cancer surgeries? Examining Acute complication rates from a 13-year NSQIP analysis. Cancers. 2019;11(2):253. https:\/\/doi.org\/10.3390\/cancers11020253.","journal-title":"Cancers"},{"issue":"11","key":"18776_CR27","doi-asserted-by":"publisher","first-page":"4502","DOI":"10.1245\/s10434-020-08574-8","volume":"27","author":"MJ Stein","year":"2020","unstructured":"Stein MJ, Karir A, Arnaout A, et al. Quality-of-life and surgical outcomes for breast cancer patients treated with therapeutic reduction mammoplasty versus mastectomy with immediate reconstruction. Ann Surg Oncol. 2020;27(11):4502\u201312. https:\/\/doi.org\/10.1245\/s10434-020-08574-8.","journal-title":"Ann Surg Oncol."},{"issue":"9","key":"18776_CR28","doi-asserted-by":"publisher","first-page":"2533","DOI":"10.1245\/s10434-008-9996-9","volume":"15","author":"J Kootstra","year":"2008","unstructured":"Kootstra J, Hoekstra-Weebers JE, Rietman H, et al. Quality of life after sentinel lymph node biopsy or axillary lymph node dissection in stage I\/II breast cancer patients: a prospective longitudinal study. Ann Surg Oncol. 2008;15(9):2533\u201341. https:\/\/doi.org\/10.1245\/s10434-008-9996-9.","journal-title":"Ann Surg Oncol."},{"issue":"5","key":"18776_CR29","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1177\/0272989X12454579","volume":"32","author":"DM Eddy","year":"2012","unstructured":"Eddy DM, Hollingworth W, Caro JJ, et al. Model transparency and validation: a report of the ISPOR-SMDM modeling good research practices task force-7. Med Decis Making. 2012;32(5):733\u201343. https:\/\/doi.org\/10.1177\/0272989X12454579.","journal-title":"Med Decis Making."},{"key":"18776_CR30","doi-asserted-by":"publisher","unstructured":"Husereau D, Drummond M, Augustovski F, et al.; CHEERS 2022 ISPOR Good Research Practices Task Force. Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) Statement: Updated Reporting Guidance for Health Economic Evaluations. BJOG. 2022;129(3):336-344. https:\/\/doi.org\/10.1111\/1471-0528.17012.","DOI":"10.1111\/1471-0528.17012"},{"issue":"1","key":"18776_CR31","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1097\/SLA.0b013e3182125b26","volume":"254","author":"TA King","year":"2011","unstructured":"King TA, Gurevich I, Sakr R, Patil S, Stempel M, Morrow M. Occult malignancy in patients undergoing contralateral prophylactic mastectomy. Ann Surg. 2011;254(1):2\u20137. https:\/\/doi.org\/10.1097\/SLA.0b013e3182125b26.","journal-title":"Ann Surg."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-18776-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-025-18776-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-18776-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T15:48:46Z","timestamp":1773330526000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-025-18776-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,27]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["18776"],"URL":"https:\/\/doi.org\/10.1245\/s10434-025-18776-7","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,27]]},"assertion":[{"value":"21 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Judy Boughey has received research funding paid to her institution from Eli Lilly, SimBioSys, and Quantum Leap Healthcare and has served on a data and safety monitoring board for Cairn Surgical.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}